Tiffany Lu, MD, MS is an Associate Professor of Medicine and Psychiatry at the Albert Einstein College of Medicine in Bronx, New York. She joined New York City Health & Hospitals/Jacobi in 2024 as Associate Director of Addiction Services, where she is currently focused on developing a hospital-based opioid treatment program and integrating harm reduction practices in caring for people with substance use disorders.

Prior to joining Jacobi, Dr Lu was the Medical Director of Montefiore Medical Center’s Buprenorphine Treatment Network, where she led the implementation of primary care-based opioid use disorder treatment across 7 community health centers and founded the Addiction Medicine ‘Bridge’ Clinic to provide coordinated care people with substance use disorders. Dr. Lu was also Principal Investigator of several federal and municipal grants, including the SAMHSA award to expand addiction education for medical students and residents at Einstein and NYC Department of Health contracts to implement addiction nurse care management in primary care clinics at Montefiore.

Dr. Lu graduated from the University of California in San Francisco School of Medicine and the Primary Care Internal Medicine Residency Program at Massachusetts General Hospital. She holds a Masters of Science in Clinical Research Methods from Albert Einstein College of Medicine. She is board certified in Internal Medicine and Addiction Medicine, and is active with the American Society of Addiction Medicine as an elected member of the Quality Improvement Council and Education Committee Chair for the state chapter.

Original Research

Singh-Tan S, Torres-Lockhart K, Jakubowski A, Lu T, Starrels J, De Lima P, Arnsten J, Nahvi S, Southern W. Addiction consult service and inpatient outcomes among patients with alcohol use disorder. J Gen Intern Med. 2023 Apr 26:1–8. doi: 10.1007/s11606-023-08202-7. PMID: 37100986; PMCID: PMC10132408.

Jakubowski A, Singh-Tan S, Torres-Lockhart K, Nahvi S, Stein M, Lu T. Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation. Addict Sci Clin Pract. 2023 May 18;18(1):31. doi: 10.1186/s13722-023-00386-x. PMID: 37198707; PMCID: PMC10193697.

Khalid L, Cunningham CO, Deng Y, Masyukova M,...Lu T. Cascade of care for office-based buprenorphine treatment in Bronx community clinics. J Subst Abuse Treat. 2022 Aug;139:108778. doi: 10.1016/j.jsat.2022.108778. Epub 2022 Apr 9. PMID: 35428524.

Cunningham CO, Khalid L, Deng Y,…Lu T. A comparison of office-based buprenorphine treatment outcomes in Bronx community clinics before versus during the COVID-19 pandemic. J Subst Abuse Treat. 2022 Apr;135:108631. doi: 10.1016/j.jsat.2021.108641. Epub 2021 Oct 27. PMID: 34863608

Jakubowski A, Lu T, Direnno F, Jadow B, Giovanniello A, Cunningham CO, Fox AD. Same-day vs. delayed buprenorphine prescribing and patient retention in an office-based buprenorphine treatment program. J Subst Abuse Treat. 2020 Dec;119:108140. doi: 10.1016/j.jsat.2020.108140. PMID: 33138925.

Clinical Guidelines, Reviews, and Chapters

Lu T. Treatment of Opioid Use Disorder. 2023 Sept 12. In: New York State Department of Health AIDS Institute – Clinical Guidelines Program. Available from: https://www.hivguidelines.org/opioid-use-disorder

Torres-Lockhart KE, Lu T, Weimer MB, Stein MR, and Cunningham CO. Clinical management of opioid withdrawal. Addiction. 2022 Sept; 117(9):2540-2550. doi: 10.1111/add.15818. Epub 2022 Feb 22. PMID: 35112746

Lu T, Stein M, and Fox AD. Primary care management of adults with opioid use disorder. In: UpToDate, Post TW (Ed). UpToDate, Waltham, MA; 2021.

Slawek D, Lu T, Hayes B, and Fox AD. Caring for patients with opioid use disorder – what clinicians should know about comorbid medical conditions. Psych Res Clin Pract 2019;1:16-26. doi: 10.1176/appi.prcp.20180005